Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Stroke & Vascular Excellence Forum

Stroke & Vascular
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

The Neurologist Is In, Episode 2: Teaming Up in the Stroke Unit and Beyond With Dr Mona Bahouth and Dr Deborah Dang
Podcasts
The Neurologist Is In, Episode 2: Teaming Up in the Stroke Unit and Beyond With Dr Mona Bahouth and Dr Deborah Dang
01/22/2021
In episode 2, Rachel Marie E. Salas, MD, interviews Mona Bahouth, MD, PhD, and Deborah Dang, PhD, RN, about the Johns Hopkins TeamingUP Model©, an interprofessional, patient-centered model currently being studied in the Johns Hopkins Hospital...
In episode 2, Rachel Marie E. Salas, MD, interviews Mona Bahouth, MD, PhD, and Deborah Dang, PhD, RN, about the Johns Hopkins TeamingUP Model©, an interprofessional, patient-centered model currently being studied in the Johns Hopkins Hospital...
In episode 2, Rachel Marie E....
01/22/2021
Neurology
A Review of Key Thrombectomy, ICH Trials From 2020
Podcasts
A Review of Key Thrombectomy, ICH Trials From 2020
01/18/2021
In this podcast, Neurology Learning Network's Stroke & Vascular Section Editor Amrou Sarraj, MD, discusses important thrombectomy and intracerebral hemorrhage trial data that surfaced in 2020, including the BASILAR trial, RESILIENT trial, and...
In this podcast, Neurology Learning Network's Stroke & Vascular Section Editor Amrou Sarraj, MD, discusses important thrombectomy and intracerebral hemorrhage trial data that surfaced in 2020, including the BASILAR trial, RESILIENT trial, and...
In this podcast, Neurology...
01/18/2021
Neurology
Intravenous Thrombolysis in 2020: A Year in Review
Podcasts
Intravenous Thrombolysis in 2020: A Year in Review
01/11/2021
In this podcast, Neurology Learning Network's Stroke & Vascular Section Editor Amrou Sarraj, MD, reviews major intravenous thrombolysis trial data that emerged in 2020, including data for extending thrombolysis beyond the traditional 4.5-hour...
In this podcast, Neurology Learning Network's Stroke & Vascular Section Editor Amrou Sarraj, MD, reviews major intravenous thrombolysis trial data that emerged in 2020, including data for extending thrombolysis beyond the traditional 4.5-hour...
In this podcast, Neurology...
01/11/2021
Neurology
This Year in Stroke Prevention: A Review of New Trial Data
Podcasts
This Year in Stroke Prevention: A Review of New Trial Data
12/31/2020
In this podcast, Neurology Learning Network's Stroke & Vascular Section Editor Amrou Sarraj, MD, gives a snapshot of key stroke prevention trial data that were unveiled in 2020—the THALES trial, the RIVER trial, and the Treat Stroke to Target...
In this podcast, Neurology Learning Network's Stroke & Vascular Section Editor Amrou Sarraj, MD, gives a snapshot of key stroke prevention trial data that were unveiled in 2020—the THALES trial, the RIVER trial, and the Treat Stroke to Target...
In this podcast, Neurology...
12/31/2020
Neurology
Could a Stroke Alarm Clock Play a Role in Acute Stroke Management?
Q&As
Could a Stroke Alarm Clock Play a Role in Acute Stroke Management?
11/23/2020
In a randomized study, researchers investigated whether using a stroke alarm clock that demands active feedback from stroke physicians could help accelerate acute stroke care. Neurology Learning Network discussed these findings further with...
In a randomized study, researchers investigated whether using a stroke alarm clock that demands active feedback from stroke physicians could help accelerate acute stroke care. Neurology Learning Network discussed these findings further with...
In a randomized study,...
11/23/2020
Neurology
Amrou Sarraj, MD: Selecting the Right Candidates for PFO Closure to Prevent Stroke Recurrence
Podcasts
Amrou Sarraj, MD: Selecting the Right Candidates for PFO Closure to Prevent Stroke Recurrence
10/08/2020
In part 3 of this podcast series, Dr Sarraj discusses factors that determine whether PFO closure is beneficial for each patient, scores and imaging modalities that can be used to help determine this, and patient expectations following the...
In part 3 of this podcast series, Dr Sarraj discusses factors that determine whether PFO closure is beneficial for each patient, scores and imaging modalities that can be used to help determine this, and patient expectations following the...
In part 3 of this podcast...
10/08/2020
Neurology
Amrou Sarraj, MD: Evidence for PFO Closure vs Medical Management Alone in Reducing Stroke Recurrence
Podcasts
Amrou Sarraj, MD: Evidence for PFO Closure vs Medical Management Alone in Reducing Stroke Recurrence
10/02/2020
In part 2 of this podcast series, Dr Sarraj gives an overview of evidence from various clinical trials for the closure of patent foramen ovale (PFO) compared with medical management alone for the prevention of stroke recurrence among patients...
In part 2 of this podcast series, Dr Sarraj gives an overview of evidence from various clinical trials for the closure of patent foramen ovale (PFO) compared with medical management alone for the prevention of stroke recurrence among patients...
In part 2 of this podcast...
10/02/2020
Neurology
Neal S. Parikh, MD, on Smoking Rates Among Survivors of Acute Ischemic Stroke
Podcasts
Neal S. Parikh, MD, on Smoking Rates Among Survivors of Acute Ischemic Stroke
10/01/2020
In this podcast, Dr Parikh discusses the findings of his recent study, which indicated that, smoking rates have not decreased over the past 2 decades among survivors of acute ischemic stroke, unlike the general population. He also reviews...
In this podcast, Dr Parikh discusses the findings of his recent study, which indicated that, smoking rates have not decreased over the past 2 decades among survivors of acute ischemic stroke, unlike the general population. He also reviews...
In this podcast, Dr Parikh...
10/01/2020
Neurology
Amrou Sarraj, MD: Approaching PFO-Associated Stroke from a Neurologist’s Standpoint
Podcasts
Amrou Sarraj, MD: Approaching PFO-Associated Stroke from a Neurologist’s Standpoint
09/28/2020
In part 1 of this podcast series, Dr Sarraj discusses the etiology and special characteristics of patients with patent foramen ovale (PFO) and PFO-associated stroke compared with patients with traditional stroke risk factors, as well as how...
In part 1 of this podcast series, Dr Sarraj discusses the etiology and special characteristics of patients with patent foramen ovale (PFO) and PFO-associated stroke compared with patients with traditional stroke risk factors, as well as how...
In part 1 of this podcast...
09/28/2020
Neurology
Shumei Man, MD, PhD, on Shortening Door-to-Needle Times in Acute Ischemic Stroke
Podcasts
Shumei Man, MD, PhD, on Shortening Door-to-Needle Times in Acute Ischemic Stroke
08/11/2020
In this podcast, Dr Man discusses the findings from her recent study, which indicated that shorter thrombolytic door-to-needle times were associated with lower all-cause readmission and lower all-cause mortality at 1 year among Medicare...
In this podcast, Dr Man discusses the findings from her recent study, which indicated that shorter thrombolytic door-to-needle times were associated with lower all-cause readmission and lower all-cause mortality at 1 year among Medicare...
In this podcast, Dr Man...
08/11/2020
Neurology

Advertisement

Advertisement

News

News
5 Questions on the Optimization of Patient Selection for Endovascular Therapy in AIS
04/07/2020
Neurology Consultant spoke with the SELECT trial national principal investigator and lead author Amrou Sarraj, MD, whose trial shed light on how the use of imaging modalities can be optimized following the onset of acute ischemic stroke in...
Neurology Consultant spoke with the SELECT trial national principal investigator and lead author Amrou Sarraj, MD, whose trial shed light on how the use of imaging modalities can be optimized following the onset of acute ischemic stroke in...
Neurology Consultant spoke with...
04/07/2020
Neurology
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
News
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
08/08/2024
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive...
08/08/2024
Neurology
brain waves
News
High-Dose Statins May Not Benefit Patients With Mild Ischemic Stroke
08/08/2024
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose...
08/08/2024
Neurology
An illustration of a healthcare provider conducting a telehealth appointment
News
Teleneurology Visits Acceptable to Patients Across Neurologic Conditions
08/05/2024
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic...
08/05/2024
Neurology
The US Food and Drug Administration headquarters sign.
News
DMD Gene Therapy Indication Expanded to Include Boys 4 and Older
08/01/2024
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an...
08/01/2024
Neurology
A person walks down a boarded path with sunlight and trees in the background
News
Backward Walking Speed Reserve Reflects Disease Severity in Patients With MS
07/30/2024
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve,...
07/30/2024
Neurology
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
News
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
07/29/2024
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod...
07/29/2024
Neurology
A middle-aged male running
News
Moderate Physical Activity May Mitigate ALS Risk for Male Patients
07/25/2024
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in...
07/25/2024
Neurology
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
News
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
07/23/2024
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug...
07/23/2024
Neurology
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
News
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
07/22/2024
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was...
07/22/2024
Neurology
a hand breaks a wooden human figurine in half
News
Atogepant Reduces Migraine Days in Patients With Pain Medication Overuse
07/18/2024
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related...
07/18/2024
Neurology

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement